Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1686050803;50804;50805 chr2:178611651;178611650;178611649chr2:179476378;179476377;179476376
N2AB1521945880;45881;45882 chr2:178611651;178611650;178611649chr2:179476378;179476377;179476376
N2A1429243099;43100;43101 chr2:178611651;178611650;178611649chr2:179476378;179476377;179476376
N2B779523608;23609;23610 chr2:178611651;178611650;178611649chr2:179476378;179476377;179476376
Novex-1792023983;23984;23985 chr2:178611651;178611650;178611649chr2:179476378;179476377;179476376
Novex-2798724184;24185;24186 chr2:178611651;178611650;178611649chr2:179476378;179476377;179476376
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: H
  • RefSeq wild type transcript codon: CAT
  • RefSeq wild type template codon: GTA
  • Domain: Fn3-11
  • Domain position: 9
  • Structural Position: 11
  • Q(SASA): 0.6347
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
H/N None None 0.999 N 0.531 0.324 0.330069100803 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0
H/R rs2154199864 None 1.0 N 0.667 0.312 0.301455362545 gnomAD-4.0.0 4.77897E-06 None None None None N None 0 0 None 0 2.7818E-05 None 0 0 5.72249E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
H/A 0.599 likely_pathogenic 0.5128 ambiguous -0.291 Destabilizing 0.999 D 0.664 neutral None None None None N
H/C 0.3425 ambiguous 0.2859 benign 0.405 Stabilizing 1.0 D 0.792 deleterious None None None None N
H/D 0.6996 likely_pathogenic 0.5571 ambiguous -0.139 Destabilizing 1.0 D 0.749 deleterious N 0.468061998 None None N
H/E 0.5835 likely_pathogenic 0.4743 ambiguous -0.074 Destabilizing 0.999 D 0.55 neutral None None None None N
H/F 0.5137 ambiguous 0.4871 ambiguous 0.642 Stabilizing 1.0 D 0.777 deleterious None None None None N
H/G 0.7301 likely_pathogenic 0.6482 pathogenic -0.63 Destabilizing 0.999 D 0.69 prob.neutral None None None None N
H/I 0.5384 ambiguous 0.4573 ambiguous 0.61 Stabilizing 1.0 D 0.789 deleterious None None None None N
H/K 0.3386 likely_benign 0.2985 benign -0.264 Destabilizing 1.0 D 0.745 deleterious None None None None N
H/L 0.291 likely_benign 0.2205 benign 0.61 Stabilizing 1.0 D 0.762 deleterious N 0.483046877 None None N
H/M 0.677 likely_pathogenic 0.6198 pathogenic 0.457 Stabilizing 1.0 D 0.767 deleterious None None None None N
H/N 0.2906 likely_benign 0.2234 benign -0.243 Destabilizing 0.999 D 0.531 neutral N 0.474279092 None None N
H/P 0.8806 likely_pathogenic 0.8225 pathogenic 0.334 Stabilizing 1.0 D 0.784 deleterious N 0.475913197 None None N
H/Q 0.3138 likely_benign 0.2489 benign -0.057 Destabilizing 1.0 D 0.667 neutral N 0.446839926 None None N
H/R 0.1728 likely_benign 0.1342 benign -0.825 Destabilizing 1.0 D 0.667 neutral N 0.439234398 None None N
H/S 0.5123 ambiguous 0.4211 ambiguous -0.231 Destabilizing 1.0 D 0.751 deleterious None None None None N
H/T 0.4946 ambiguous 0.4087 ambiguous -0.066 Destabilizing 1.0 D 0.785 deleterious None None None None N
H/V 0.4524 ambiguous 0.3753 ambiguous 0.334 Stabilizing 1.0 D 0.796 deleterious None None None None N
H/W 0.7058 likely_pathogenic 0.629 pathogenic 0.802 Stabilizing 1.0 D 0.789 deleterious None None None None N
H/Y 0.2542 likely_benign 0.2039 benign 1.003 Stabilizing 0.999 D 0.549 neutral N 0.482082755 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.